Qbcon Unclaimed

QBCon is a business solution development and supply company that specialises in LIMS, ERP, CMMS and BI systems

For L.B. Bohle continuous production processes are shaping the future of pharmaceutical solid dosage production. The advantages of this kind of processing are obvious, both from the economic and the product quality point of view, which overlap in some parts. By applying continuous manufacturing, a distinct reduction in machine footprint is possible. The required machines can be designed smaller, as they can produce the equal volume of materials as large batch processes solely by increasing the production time. Furthermore, unit operations can be combined in a single step. This leads to smaller designated areas that have to be installed under GMP (good manufacturing practice) conditions, which is a great potential to save expenses. Storage and transport of intermediates from different production sites, likely in different countries, do not occur, as the different unit operations are connected to each other. The amount of material produced only depends on the throughput and the production time of the machines and is thereby variable. This means that to scale up from smaller to bigger machines is not an issue and the production of material can easily be adapted to market demands. Additionally, this implicates the possibility of shorter times-to-market, as the market production of a product can be conducted on a pilot scale line.